- Home
- CARE vs CRVS Comparison
CARE vs CRVS Comparison
Compare CARE & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CARE | CRVS |
|---|---|---|
| Founded | 1974 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.8M | 634.0M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CARE | CRVS |
|---|---|---|
| Price | $19.98 | $8.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $13.75 |
| AVG Volume (30 Days) | 80.4K | ★ 1.0M |
| Earning Date | 01-22-2026 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.48 | N/A |
| EPS | ★ 1.36 | N/A |
| Revenue | ★ $154,517,000.00 | N/A |
| Revenue This Year | $10.69 | N/A |
| Revenue Next Year | $14.79 | N/A |
| P/E Ratio | $14.66 | ★ N/A |
| Revenue Growth | ★ 20.24 | N/A |
| 52 Week Low | $13.61 | $2.54 |
| 52 Week High | $20.53 | $9.60 |
Technical Indicators
Market Signals| Indicator | CARE | CRVS |
|---|---|---|
| Relative Strength Index (RSI) | 78.46 | 51.32 |
| Support Level | $18.21 | $8.31 |
| Resistance Level | $20.12 | $9.60 |
| Average True Range (ATR) | 0.35 | 0.54 |
| MACD | 0.22 | -0.09 |
| Stochastic Oscillator | 96.69 | 26.75 |
Price Performance
Historical ComparisonAbout CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).